Hypokalemia Periodic Paralysis in Subtle Thyrotoxicosis with Renal Insufficiency
DOI:
https://doi.org/10.66266/inajemd.v1i1.8Keywords:
periodic paralysis, hypokalemia, primary hyperthyroidism, subtle thyrotoxicosisAbstract
Hypokalemia is one of the frequently observed electrolyte imbalances in clinical practice. The clinical manifestations range from asymptomatic to significant manifestation, such as paralysis. Here we report a case of 31-years-old female admitted to our emergency department with chief complaint of acute onset of paralysis in lower extremities. Vital signs showed slight tachycardia. The physical examinations were all normal. Motoric examination showed paraparesis in lower extremities with normal sensory function. Upon admission, laboratory tests showed severe hypokalemia (1.5 mmol/L) with renal insufficiency. The patient got hypokalemia corrected with both potassium oral supplementation and potassium infusion. Thyroid function tests showed hyperthyroidism and the diagnosis of thyrotoxic periodic paralytic (TPP) was made. This case report highlights the importance of early diagnosis and prompt treatment of hypocalemia in TPP patient.
Downloads
References
1. Greco A, Rabito G, Pironi M, Bissig M, Parlato S, Andreocchi L, et al. Hypokalaemia in hospitalised patients. Swiss Med Wkly 2016;146:w14320.
2. Eliacik E, Yildirim T, Sahin U, Kizilarslanoglu C, Tapan U, Aybal-Kutlugun A, et al. Potassium abnormalities in current clinical practice: Frequency, causes, severity and management. Med Princip and Pract 2015;24:271–5.
3. Crop MJ, Hoorn EJ, Lindemans J, Zietse R. Hypokalaemia and subsequent hyperkalaemia in hospitalized patients. Nephrol Dial Transplant 2007;22:3471–7.
4. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 2004;43:155–61.
5. Fontaine B. Chapter 1 Periodic Paralysis. Adv Genet 2008;63:3–23.
6. Ke Q, Luo B, Qi M, Du Y, Wu W. Gender differences in penetrance and phenotype in hypokalemic periodic paralysis. Muscle Nerve 2013;47:41–5.
7. Patel H, Wilches LV, Guerrero J. Thyrotoxic periodic paralysis: Diversity in America. J of Emerg Med 2014;46:760–2.
8. Miller TM, Dias Da Silva ; M R, Miller ; H A, Kwiecinski ; H, Mendell ; J R, Tawil ; R, et al. Correlating phenotype and genotype in the periodic paralyses. Neurol, 63(9); 2004. 1647-1655
9. Lin SH. Thyrotoxic periodic paralysis. Mayo Clin Proc 2005;80:99–105.
10. Stedwell RE, Allen KM, Binder LS. Hypokalemic paralyses: presentation, and therapy. Am J Emerg Med 1992;10:143-148.
11. Lin SH, Huang CL. Mechanism of thyrotoxic periodic paralysis. J of the Am Soc of Nephrol 2012;23:985–8.
12. Clarine LHS, Hosein N. Thyrotoxic periodic paralysis: a review of cases in the last decade. AACE Clin Case Rep 2015;1:e182–6.
13. Liu Z, Braverman LE, Malabanan A. Thyrotoxic periodic paralysis in a hispanic man after the administration of prednisone. Endocrine Pract n.d.;12.
14. Chakraborty J, Chakraborty S, Moitra R. Thyrotoxic periodic paralysis: an update. J Endocrinol Metab 2020;10:60–2.
15. MacIel RMB, Lindsey SCS, Dias Da Silva MR. Novel etiopathophysiological aspects of thyrotoxic periodic paralysis. Nat Rev Endocrinol 2011;7:657–67.
16. Schöfl C, Becker C, Prank K, Mü Z, Brabant G. Twenty-four-hour rhythms of plasma catecholamines and their relation to cardiovascular parameters in healthy young men. Eur J of Endocrinol, 137(6), 675-683.
17. Chang CC, Cheng CJ, Sung CC, Chiueh TS, Lee CH, Chau T, et al. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: Focus on symptomatology and precipitants. Eur J Endocrinol 2013;169:529–36. https://doi.org/10.1530/EJE-13-0381.
18. Lin S-H, Lin Y-F, Halperin ML. Hypokalaemia and paralysis. QJM: An Int J Med 2001;94.
19. Lopez S, Henderson SO. Electrocardiogram changes in thyrotoxic periodic paralysis. West J of Emerg Med 2012;13:512–3.
20. Hsu YJ, Lin YF, Chau T, Liou JT, Kuo SW, Lin SH. Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis. Am J Med Sci 2003;326 :128–32.
21. Wang HF, Tsai SC, Pan MS, Shiao CC. Complete heart block during potassium therapy in thyrotoxic periodic paralysis. J Emerg Med 2013;44:61–4.
22. Statland JM, Fontaine B, Hanna MG, Johnson NE, Kissel JT, Sansone VA, et al. Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve 2018;57:522–30.
23. Summachiwakij S, Sachmechi I. Rhabdomyolysis induced by nonstrenuous exercise in a patient with graves’ disease. Case Rep Endocrinol 2014;2014:1–3.
24. Goh SH. Thyrotoxic periodic paralysis: Reports of seven patients presenting with weakness in an Asian emergency department. Emerg Med J 2002;19:78–9.
25. Kelley DE, Gharib H, Kennedy FP, Duda RJ, McManis PG. Thyrotoxic periodic paralysis report of 10 cases and review of electromyographic findings. Arch Intern Med 1989;149.
26. Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ, et al. The primary periodic paralyses: Diagnosis, pathogenesis and treatment. Brain 2006;129:8–17.
27. Manoukian MA, Foote JA, Crapo LM. Clinical and Metabolic Features of Thyrotoxic Periodic Paralysis in 24 Episodes. Arch Intern Med 1999; 159(6), 601-606.
28. Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kid Dis 2001;37:620–3.
29. Shayne P, Hart A. Thyrotoxic Periodic Paralysis terminated with intravenous propranolol. Ann Emerg Med 1994; 24(4), 736-740.
30. Birkhahn RH, Gaeta TJ, Melniker L. Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. J Emerg Med 2000; 18.2: 199-202.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD) the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
© Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD). Published by the Indonesian Society of Endocrinology (PERKENI).
